Vaxcyte, Inc. (PCVX)
Vaxcyte, Inc. is a biotechnology firm in the clinical development stage, dedicated to creating innovative protein-based vaccines. Its primary objective is to either prevent or manage bacterial infectious diseases. The company's leading vaccine candidate is VAX-24, an experimental 24-valent pneumococcal conjugate vaccine currently undergoing Phase 1/2 clinical trials, intended to address invasive pneumococcal disease and pneumonia. Beyond its flagship candidate, Vaxcyte is also advancing several other vaccine programs: VAX-XP, designed to offer protection against emergent bacterial strains and counter antimicrobial resistance; VAX-A1, a conjugate vaccine formulation aimed at Group A Streptococcus; and VAX-PG, a novel protein vaccine specifically developed to target the key pathogen responsible for periodontitis. The organization, which was initially established as SutroVax, Inc., officially rebranded as Vaxcyte, Inc. in May 2020. Founded in 2013, its corporate headquarters are situated in San Carlos, California.
Sector: Biological Products, (No Diagnostic Substances)
Industry: Biotechnology
Vaxcyte, Inc.
NASDAQ:PCVXHealthcare · Biotechnology
-0.93%$62.03
AH$61.99-0.06%vs close
Mkt Cap$9.76B
Float130.56M
O/S157.39M
Vol
$ Vol
RVOL
Inst Own-
SI11.2%
Earnings
Dilution
Financials Summary
Revenue$0
Net Income-$766.63M
Total Assets$3.05B
Free Cash Flow-$669.29M
Debt & Equity
Debt 8%
Equity 92%
Total Debt$228.84M
Total Equity$2.69B
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in PCVX's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$3.05B
Liabilities$360.45M
Accounts Receivable$46.56M
Accounts Payable$70.9M
Inventory$0
PP&E (Net)$491.72M
Goodwill$0
Intangible Assets$0
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 |
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | - | - | - | - | - | - | - | - | - |
| Cost of Revenue | $0 | $0 | $0 | $0 | $0 | $1.41M | $1.23M | $1.04M | $0 |
| Gross Profit | $0 | $0 | $0 | $0 | $0 | -$1.41M | -$1.23M | -$1.04M | $0 |
| Gross Margin | - | - | - | - | - | - | - | - | - |
| Research and Development | $794.31M | $476.64M | $332.34M | $169.45M | $78.41M | $73.56M | $45.61M | $30.14M | $12.79M |
| Selling, General, and Administrative | $129.37M | $92.9M | $60.7M | $39.81M | $25.26M | $14.61M | $7.31M | $5.39M | $5.05M |
| Other | $0 | $0 | $75M | $23M | $0 | $0 | $0 | $5.18M | $0 |
| Total Operating Expenses | $923.67M | $569.55M | $468.04M | $232.26M | $103.67M | $88.18M | $52.92M | $35.53M | $17.4M |
| Operating Income (EBIT) | -$923.67M | -$569.55M | -$468.04M | -$232.26M | -$103.67M | -$89.58M | -$54.15M | -$35.53M | -$17.83M |
| Operating Margin | - | - | - | - | - | - | - | - | - |
| Interest Expense | $0 | $0 | $0 | $2K | $7K | $7K | $40K | $75K | $0 |
| Interest Income | $119.72M | $109.99M | $62.91M | $8.36M | $344K | $244K | $632K | $903K | $164K |
| Other Income (Expense) | $157.05M | $105.62M | $65.78M | $8.77M | $3.59M | $364K | $3.88M | $6.05M | $595K |
| Income Before Tax (EBT) | -$766.63M | -$463.93M | -$402.27M | -$223.49M | -$100.08M | -$89.22M | -$50.27M | -$29.48M | -$17.24M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$766.63M | -$463.93M | -$402.27M | -$223.49M | -$100.08M | -$89.22M | -$50.27M | -$29.48M | -$17.24M |
| Net Income Margin | - | - | - | - | - | - | - | - | - |
| Supplementary Data | |||||||||
| EPS | -5.63 | -3.80 | -4.14 | -3.44 | -1.93 | -2.97 | -14.10 | -8.12 | -4.84 |
| Diluted EPS | -5.63 | -3.80 | -4.14 | -3.44 | -1.93 | -2.97 | -14.10 | -8.12 | -4.83 |
| Weighted Average OS | 136.09M | 122.00M | 97.16M | 64.88M | 51.92M | 29.55M | 3.79M | 3.63M | 3.56M |
| EBITDA | -$741.77M | -$448.08M | -$392.1M | -$214.03M | -$96.61M | -$87.81M | -$49M | -$28.37M | -$17.21M |
| EBITDA Margin | - | - | - | - | - | - | - | - | - |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 |
| Assets | |||||||||
| Current Assets | |||||||||
| Cash and Cash Equivalents | $173.96M | $387.88M | $397.45M | $834.66M | $68.98M | $386.2M | $58.98M | $66.09M | $36.14M |
| Short-Term Investments | $1.39B | $1.36B | $682.78M | $96.72M | $176.99M | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $1.56B | $1.75B | $1.08B | $931.38M | $245.97M | $386.2M | $58.98M | $66.09M | $36.14M |
| Accounts Receivable | $46.56M | $20.66M | $3.61M | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $2.8M | $20.11M | $5.96M | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Current Assets | $1.63B | $1.79B | $1.1B | $942.55M | $256.35M | $389M | $61.72M | $66.67M | $36.35M |
| Long-Term Assets | |||||||||
| Property, Plant & Equipment Net | $491.72M | $270.15M | $110.62M | $31.65M | $35.91M | $3.27M | $3.39M | $3.41M | $2.97M |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $883.13M | $1.39B | $162.68M | $26.55M | $27.12M | $0 | $0 | $0 | $0 |
| Deferred Tax Assets | $43.25M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $508K | $65.68M | $38.66M | $5.43M | $4.96M | $550K | $584K | $723K | $311K |
| Total Long-Term Assets | $1.42B | $1.72B | $311.96M | $63.62M | $67.99M | $3.82M | $3.98M | $4.13M | $3.28M |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $3.05B | $3.51B | $1.41B | $1.01B | $324.34M | $392.83M | $65.7M | $70.8M | $39.63M |
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts Payable | $70.9M | $48.45M | $14.59M | $9.79M | $6.76M | $29.79M | $3.38M | $2.83M | $1.81M |
| Short-Term Debt | $6.12M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$297K | $0 |
| Other Current Liabilities | $105.72M | $20.55M | $11.06M | $1.18M | $3.46M | $298K | $433K | $2.4M | $850K |
| Total Current Liabilities | $205.75M | $140.18M | $145.34M | $40.52M | $28.72M | $46.86M | $11.05M | $6.71M | $4.26M |
| Long-Term Liabilities | |||||||||
| Long-Term Debt | $111.36M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $3.76M |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $43.25M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | -$111.26M | $100K | $0 | $9K | $96K | $122K | $161.02M | $121.66M | $212K |
| Total Long-Term Liabilities | $154.7M | $65.32M | $22.11M | $12.04M | $11.6M | $122K | $161.02M | $121.82M | $4.43M |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $360.45M | $205.5M | $167.45M | $52.56M | $40.32M | $46.98M | $172.07M | $128.53M | $8.69M |
| Stockholders' Equity | |||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $117.81M | $60.07M |
| Common Stock | $134K | $128K | $98K | $82K | $56K | $54K | $7K | $6K | $6K |
| Retained Earnings | -$2.15B | -$1.39B | -$924.39M | -$522.13M | -$298.64M | -$198.56M | -$109.35M | -$59.07M | -$29.59M |
| Comprehensive Income & Other | $1.59M | -$3.87M | $179K | -$361K | -$241K | $0 | $0 | -$1.75M | $0 |
| Other Stockholders' Equity | $4.84B | $4.69B | $2.16B | $1.48B | $582.6M | $544.35M | $2.97M | $1.34M | $60.52M |
| Total Equity | $2.69B | $3.31B | $1.24B | $953.61M | $284.02M | $345.84M | -$106.37M | -$57.73M | $30.94M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $3.05B | $3.51B | $1.41B | $1.01B | $324.34M | $392.83M | $65.7M | $70.8M | $39.63M |
| Supplementary Data | |||||||||
| Total Debt | $228.84M | $71.11M | $29.22M | $17.94M | $16.78M | $0 | $161K | $458K | $4.5M |
| Net Debt | $54.88M | -$316.77M | -$368.23M | -$816.72M | -$52.2M | -$386.2M | -$58.81M | -$65.63M | -$31.64M |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 |
| Operating Activities | |||||||||
| Net Income | -$766.63M | -$463.93M | -$402.27M | -$223.49M | -$100.08M | -$89.22M | -$50.27M | -$29.48M | -$17K |
| Depreciation & Amortization | $24.86M | $15.85M | $10.17M | $9.45M | $3.46M | $1.41M | $1.23M | $1.04M | $625K |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $0 | $301K | $0 | $51K | $0 |
| Stock-Based Compensation | $138.84M | $84.82M | $48.76M | $23.65M | $10.73M | $5.43M | $1.19M | $749K | $390 |
| Changes in Working Capital: | |||||||||
| Accounts Receivable | $0 | $0 | $0 | $0 | $0 | $0 | $868K | $1.27M | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$1.19M | $0 |
| Accounts Payable | $19.91M | $34.58M | $11.22M | $2.9M | -$12.47M | $26.1M | $868K | $1.27M | $0 |
| Other Working Capital | -$23.36M | -$89.48M | $70.09M | $9.84M | -$24.54M | $9.17M | $2.17M | $550K | $1K |
| Total Working Capital Change | -$3.45M | -$54.9M | $81.32M | $12.74M | -$37.01M | $35.27M | $3.91M | $1.9M | $1K |
| Other Non-Cash Items | -$49.2M | -$34.47M | -$34.77M | $7.05M | $1.5M | $179K | -$3.2M | -$4.71M | -$624K |
| Net Cash from Operating | -$655.58M | -$452.63M | -$296.79M | -$170.6M | -$121.39M | -$46.63M | -$47.15M | -$30.47M | -$15K |
| Investing Activities | |||||||||
| Capital Expenditures | -$13.71M | -$22.43M | -$67.88M | -$5.84M | -$6.55M | -$1.16M | -$1.2M | -$1.77M | -$1K |
| Acquisitions | $0 | $0 | $0 | $0 | $0 | $50K | $0 | $1K | $0 |
| Purchases of Investments | -$1.21B | -$3.09B | -$1.33B | -$102.75M | -$336.34M | $0 | $0 | $0 | $0 |
| Sales of Investments | $1.71B | $1.2B | $624.46M | $183.17M | $130.56M | $0 | $0 | $0 | $0 |
| Other Investing Activities | -$43.26M | -$96.73M | $0 | $0 | $26K | $0 | $0 | $1K | $106 |
| Net Cash from Investing | $437.35M | -$2.01B | -$773.31M | $74.58M | -$212.31M | -$1.1M | -$1.2M | -$1.77M | -$1K |
| Financing Activities | |||||||||
| Debt Repaid | - | - | - | - | - | $61K | $278K | $283K | $188K |
| Common Stock Issuance | $13.01M | $2.44B | $636.04M | $856.48M | $13.9M | $264.01M | $0 | $62.47M | $0 |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | -$10.99M | $12.85M | $3.77M | $5.07M | $3.9M | $1.04M | -$655K | $128K | $232K |
| Net Cash from Financing | $2.01M | $2.45B | $639.81M | $861.55M | $17.8M | $374.87M | $41.57M | $62.19M | $44K |
| Forex Effect | $2.44M | $426K | -$6.69M | $137K | -$439K | $87K | -$341K | $0 | $0 |
| Net Change in Cash | -$213.77M | -$9.36M | -$436.97M | $765.67M | -$316.34M | $327.22M | -$7.11M | $29.95M | $28K |
| Supplementary Data | |||||||||
| Operating Cash Flow | -$655.58M | -$452.63M | -$296.79M | -$170.6M | -$121.39M | -$46.63M | -$47.15M | -$30.47M | -$15K |
| Capital Expenditure | -$13.71M | -$22.43M | -$67.88M | -$5.84M | -$6.55M | -$1.16M | -$1.2M | -$1.77M | -$1K |
| Free Cash Flow | -$669.29M | -$475.05M | -$364.67M | -$176.44M | -$127.95M | -$47.78M | -$48.34M | -$32.24M | -$16K |
| Cash at Beginning | $389.19M | $398.55M | $835.53M | $69.86M | $386.2M | $58.98M | $66.09M | $36.14M | $8K |
| Cash at End | $175.43M | $389.19M | $398.55M | $835.53M | $69.86M | $386.2M | $58.98M | $66.09M | $36K |